USPTO Patent Application for Aortic Disease Treatment Apparatus
Summary
The USPTO has published a new patent application (US20260083545A1) for an apparatus designed for the endovascular treatment of aortic diseases. The application, filed by Braile Biomédica Indústria Comércio e Representações Ltda., details a stent graft with both balloon-expandable and self-expanding sections for improved positioning and fixation.
What changed
The United States Patent and Trademark Office (USPTO) has published a new patent application, US20260083545A1, concerning an apparatus for treating aortic diseases. The application describes a stent graft apparatus featuring a combination of balloon-expandable and self-expanding sections designed for enhanced accuracy in positioning and anatomical adaptability during endovascular treatment of conditions such as aneurysms and dissections.
This publication represents a new patent application and does not impose immediate regulatory obligations. However, it signifies potential future developments in medical device technology for cardiovascular treatments. Companies involved in the manufacturing or development of medical devices, particularly those related to cardiovascular prosthetics, should note this application as it may influence future market offerings or patent landscapes in this area.
Archived snapshot
Mar 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
APPARATUS FOR TREATMENT OF AORTA DISEASE WITH A BALLOON EXPANDABLE SECTION
Application US20260083545A1 Kind: A1 Mar 26, 2026
Assignee
Braile Biomédica Indústria Comércio e Representações Ltda.
Inventors
Rafael Braile Cunha, Vinicius Ladeia Semenzim, Marco Orlandi, Antonio Rizza, Lucas Roberto Dos Santos
Abstract
A stent graft apparatus for endovascular treatment of aortic diseases includes a balloon-expandable section and a self-expanding section connected by radial sutures to form a unitary device. The balloon-expandable section comprises a metallic framework configured for deployment via balloon inflation and includes a plurality of radially equidistant radiopaque markers for fluoroscopic visualization. The self-expanding section comprises a shape-memory material configured to exert continuous radial force upon release. The connected sections are sequentially deployed through a catheter-based delivery system, allowing the balloon-expandable section to anchor the graft precisely at the treatment site before the self-expanding section is released to conform to the vessel anatomy. This configuration facilitates both accurate positioning and anatomical adaptability, reducing the risk of migration and improving fixation in complex aortic regions. The apparatus may be used to treat aneurysms, dissections, or injuries in various segments of the aorta.
CPC Classifications
A61F 2/07 A61F 2210/0004 A61F 2210/0014 A61F 2220/0008 A61F 2220/0075 A61F 2230/0006 A61F 2250/0098
Filing Date
2025-08-19
Application No.
19304192
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Prosthetics (A61F)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Prosthetics (A61F) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.